DFW Capital Partners Mergers and Acquisitions Summary

Private Equity Profile

In the last 3 years, DFW Capital Partners has invested in 6 companies.

DFW Capital Partners’ most common sectors for investment are healthcare services (21%) and business services (18%). The Firm’s most common investment types include growth capital (42%) and buyout (lbo, mbo, mbi) (28%). In total, DFW Capital Partners has invested in 14 US states and 2 different countries. Its largest (disclosed) acquisition occurred in 1999 when it acquired Sheridan Healthcare for $155M.

In the last 3 years, DFW Capital Partners has exited 5 companies. The Firm’s most common exit type is trade sale (43%). DFW Capital Partners’ largest (disclosed) exit occurred in 2014 when it sold Vidara Therapeutics for $660M.

Join Mergr to view DFW Capital Partners’ full profile and discover more middle-market private equity firms just like it.

M&A Summary

  • M&A Total Activity50
    • M&A Buy Activity29
    • M&A Sell Activity21
  • Total Sectors Invested 12
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 24

DFW Capital Partners

300 Frank W. Burr Blvd., Glenpointe Centre East, 5th Floor,
Teaneck, New Jersey 07666
United States,
(201)836-6000
www.dfwcapital.com

DFW Capital Partners, Inc. is a private equity firm that invests in high-growth middle-market service companies generating revenues $20-$100 million with an EBITDA of $3-$10 million. Specific service areas of interest include business services, industrial services, and healthcare services. DFW looks to invest $5 to $20 million per transaction. Prospective transactions include growth capital financing, acquisition financing, management buyouts, and recapitalization. DFW will not invest in start-ups, real estate, or pure R&D companies. DFW Capital Partner, Inc. was formed in 1983 and has offices in Teaneck and New Jersey.


Investment Criteria

Sectors of Interest: Business Services, Defense, Distribution, Electrical Equipment, Electronics, Gaming, Healthcare Services, Information Technology, Life Science, Machinery, Marketing, Software, Staffing

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Recapitalization

Geographic Preferences: East US, Midwest US, South US, West US

Transaction Criteria Min Max
Target Revenue 20 100
Target EBITDA 3 10
Investment Size 5 20
Enterprise Value - -
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '15 '16 '17 '18 '19 '20 T
Buy (2.0/yr) # 19 2 1 4 3 - 29
vol $155M $155M
Sell (1.0/yr) # 16 - 2 2 1 - 21
vol $1.4B $1.4B
  50

Most Recent M&A

Company Date Value Type
Regulatory and Quality Solutions LLC 2019-10-11 - Growth Capital
Monroeville, Pennsylvania · www.rqteam.com
Vertex Group Ltd. 2019-07-23 - Secondary Buyout
London, United Kingdom · www.vertexgroup.com
Superior Controls, Inc. 2019-04-17 - Add-on Acquisition
Seabrook, New Hampshire · www.superiorcontrols.com
Sev1Tech, Inc. 2019-03-15 - Growth Capital
Woodbridge, Virginia · www.sev1tech.com
Lotus Clinical Research LLC 2018-11-15 - Growth Capital
Pasadena, California · www.lotuscr.com
FLEETWASH, Inc. 2018-10-02 - Secondary Buyout
Fairfield, New Jersey · www.fleetwash.com
Restoration & Recovery 2018-07-02 - Growth Capital
Durham, North Carolina · www.rrstormwater.com
Evolution Research Group LLC 2018-05-30 - Secondary Buyout
Watchung, New Jersey · www.evolutionresearchgroup.com
ReSource Pro 2018-04-17 - Growth Capital
New York, New York · www.resourcepro.com
INSIGHT2PROFIT 2018-03-26 - Growth Capital
Cleveland, Ohio · www.insight2profit.com
View All >>

Portfolio M&A

Company Acquired Add-On/Sale Date #
Saol Therapeutics 2017-01-02 Aptevo Therapeutics, Inc. - Hyperimmune Commercial Products 2017-08-31 1
Roswell, Georgia · www.saolrx.com Seattle, Washington
Meta Pharmaceutical Services LLC 2010-08-23 NexGen RxMarketing LLC 2013-06-27 1
Blue Bell, Pennsylvania · www.metapharm.net Bensalem, Pennsylvania · www.nexgenrxmarketing.com

M&A by Sector

Sector Current # Value All-time # Value
Healthcare Services 1 (8%) - 6 (21%) 155M (100%)
Business Services 3 (25%) - 5 (17%) -
Information Technology 3 (25%) - 5 (17%) -
Life Science 3 (25%) - 5 (17%) -
Consumer Services - - 1 (3%) -
Defense - - 1 (3%) -
Electronics - - 1 (3%) -
Energy Services and Equipment 1 (8%) - 1 (3%) -
Engineering - - 1 (3%) -
Insurance 1 (8%) - 1 (3%) -
Safety/Security - - 1 (3%) -
Software - - 1 (3%) -
Total 12 - 29 $155M

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 11 (92%) - 28 (97%) 155M (100%)
  Pennsylvania 3 (25%) - 5 (17%) -
  Georgia 2 (17%) - 4 (14%) -
  New Jersey - - 3 (10%) -
  Virginia 1 (8%) - 2 (7%) -
  North Carolina 1 (8%) - 2 (7%) -
  New York 1 (8%) - 2 (7%) -
  California 1 (8%) - 2 (7%) -
  Florida - - 2 (7%) 155M (100%)
  Ohio 1 (8%) - 1 (3%) -
  Maryland 1 (8%) - 1 (3%) -
  Vermont - - 1 (3%) -
  Tennessee - - 1 (3%) -
  New Hampshire - - 1 (3%) -
  Michigan - - 1 (3%) -
United Kingdom 1 (8%) - 1 (3%) -
Domestic 11 (92%) - 28 (97%) 155M (100%)
Cross-border 1 (8%) - 1 (3%) -
Total 12 - 29 $155M

Acquisitions by Deal Type

Type Current # Value All-time # Value
Growth Capital 8 (67%) - 12 (41%) -
Buyout (LBO, MBO, MBI) 1 (8%) - 8 (28%) -
Recapitalization 1 (8%) - 5 (17%) -
Going Private - - 1 (3%) 155M (100%)
Consolidation - - 1 (3%) -
Secondary Buyout 1 (8%) - 1 (3%) -
Venture 1 (8%) - 1 (3%) -
Total 12 - 29 $155M

Exits by Deal Type

Type Total # Value
Secondary Sale 9 (43%) 161M (11%)
Trade Sale - Public Company 8 (38%) 1.3B (89%)
Trade Sale 3 (14%) -
Merger 1 (5%) -
Total 21 $1.4B

Deal Values

buy # Total
$100M to $1B 1 $155M
TOTAL $155M
Largest Sheridan Healthcare, Inc.
$155M (1999-05-01)
sell # Total
$100M to $1B 3 $1.2B
< $100M 4 $262M
TOTAL $1.4B
Largest Vidara Therapeutics, Inc.
$660M (2014-03-19)

M&A Connections

Deals %
Acquired from
PE Firm(s)
100%
5 100%
Exited to
PE Firm(s)
55%
11 55%
Strategic(s)
45%
9 45%